October 01, 2015
Article
Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).
Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses the future of treating patients with myelodysplastic syndrome (MDS).
How Love Helped Me Face Leukemia and Keep Living
How Biomarker Testing Can Inform Metastatic Breast Cancer Care
Coping With a Rare Cancer Diagnosis, Like GIST
Refining Treatment Approaches and Advancements in High-Risk Melanoma